title: [Treatment costs of malignant cervical cancer in Poland in 2011-2012--the case of Silesian Voivodeship].
abstract: OBJECTIVE
  As far as health economics is concerned, it is hard to determine the only useful tool which would disclose the actual costs associated with cancer. We analyzed hospitalization costs, which create the highest rate among all malignant cervical cancer-related medical costs. The main aim of the study was to evaluate the real costs of medical treatment in the case of patients diagnosed with cervical cancer based on the group with the primary and coexisting diagnoses.
  
  
  METHODS
  The analyzed data from 2011-2012 were obtained from the Silesian branch of the National Health Fund, which financed medical expenses due to the diagnosis of cancer in health facilities which have the agreement for such treatment.
  
  
  RESULTS
  A total of 4 540 hospitalization-related health benefits were realized, with the final total cost was PLN 8 766 547, in the presented group of 2261 patients. The most popular procedures in patients with the diagnosis from the C53 group, included chemotherapy together with oncological hospitalization (over 62%). The vast majority of the realized procedures were treatments of the reproductive system (38%) and teleradiotherapy (about 31%).
  
  
  CONCLUSIONS
  Lack of efficient procedures of data collection for cancer advancement hinders the economic analyses, which should constitute the foundation for the discussion about cost effectiveness of selected procedures. Adequate methods for the monitoring of direct and indirect costs associated with cervical cancer treatment ought to be created.
authors.forename: Tomasz
authors.initials: T
authors.lastname: Holecki
authors.forename: Karolina
authors.initials: K
authors.lastname: Sobczyk
authors.forename: Sergiusz
authors.initials: S
authors.lastname: Nawrocki
authors.forename: Joanna
authors.initials: J
authors.lastname: Woźniak-Holecka
authors.forename: Michał
authors.initials: M
authors.lastname: Skrzypek
authors.forename: Agata
authors.initials: A
authors.lastname: Bocionek
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008875:Middle Aged; D009313:National Health Programs / Q000191:economics; D009367:Neoplasm Staging / Q000191:economics; D011044:Poland / Q000453:epidemiology; D011320:Primary Health Care / Q000191:economics* / Q000706:statistics & numerical data; D012189:Retrospective Studies; D002583:Uterine Cervical Neoplasms / Q000191:economics* / Q000453:epidemiology / Q000628:therapy*; D014626:Vaginal Smears / Q000191:economics / Q000706:statistics & numerical data